Abstract:Zixuan Zhang, 1 Jing Bai, 1 Siqi Zhang, 1 Renzhen Wang, 1 Shaobing Zhu, 1 Tianyue Li, 1 Miao Zhang 2 1 Graduate Schools, Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang, People's Republic of China; 2 Acupuncture and Moxibustion 10 Departments, The Second Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang, People's Republic of China Correspondence: Miao Zhang, Acupuncture and Moxibustion 10 Departments, The Second Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang, 150001, People's Republic of China, Tel +86-13845088833, Fax +86-13114600132, Email Alzheimer's disease (AD) is a progressive neurodegenerative disease caused by multiple causes. The main pathological features of AD are β-amyloid (Aβ) deposition, hyperphosphorylation of Tau protein, and progressive neuronal loss. Pyroptosis is one of the main forms of neuronal death, which is mainly caused by the activation of Gasdermin protein by upstream signals and the release of its N-terminal domain on the cell membrane. Studies have shown that there is a close relationship between Alzheimer's disease (AD) and pyroptosis. Therefore, this paper summarizes the relationship between pyroptosis and its molecular mechanism and AD, as well as the related research of traditional Chinese medicine in the treatment of AD by regulating pyroptosis, in order to provide a new direction for the study of AD pathogenesis based on pyroptosis pathway. Keywords: Alzheimer's disease, cell pyroptosis, inflammasome, traditional Chinese medicine Alois Alzheimer, a German psychiatrist from Bavaria, first described the pathological features of a neurodegenerative disease, which was later named Alzheimer's disease, also known as Alzheimer's disease, after him. Alzheimer's disease (AD) is a common neurodegenerative disease with insidious onset and progressive exacerbation. Symptoms are usually evident after 2–3 years of onset and the disease lasts for 5–10 years, resulting in loss of neurons and synapses or cerebral atrophy, which severely affects daily life and social function. The main clinical manifestations of Alzheimer's disease are progressive memory loss, cognitive and behavioral disorders. 1 According to the study, Alzheimer's disease ranks as the 6th leading cause of death among people over 65 years old in the United Kingdom and the 5th in the United States. China, as the world's largest country in terms of population, has an elderly population of more than 200 million, and according to a national cross-sectional study in 2020, there were 15.07 million cases of dementia among people aged 60 years and older in China, including 9.83 million cases of AD, 3.92 million cases of vascular dementia, and 1.32 million cases of other dementias. Meanwhile, another national study showed that the annual cost of treating AD patients in China was 188.718 billion by 2050. 2 Alzheimer's disease, the main subtype of dementia, accounts for 60–80% of all dementia types. The global prevalence of Alzheimer's disease is expected to continue to rise as human life expectancy increases and the population ages. Three typical pathological features of AD include amyloid plaques formed by deposition of extracellular β-amyloid (Aβ) aggregates, neurofibrillary tangles (NFTs) formed by intracellular hyperphosphorylated microtubule-associated proteins (Tau proteins), and neuronal loss. 3 Current research on brain neuronal cells focuses on apoptosis, autophagy, and cellular pyroptosis, in which both apoptosis and autophagy occur in the anterior and middle stages of the disease, whereas cellular pyroptosis, as a pro-inflammatory mode of programmed cell death, occurs in the prodromal stage of AD pathogenesis, and the neuroinflammatory response it mediates also plays an important role in the pathogenesis of AD. 4 The term pyroptosis, derived from the Greek roots "pyro" (fire or fever) and "ptosis" (fall), is a new form of non-apoptotic programmed cell death that is closely related to inflammatory responses and also Known as secondary necrosis. 5 It is primarily triggered by inflammatory vesicles and is executed by a family of caspases (Caspase-1/-3/-4/-5) and Gasdermin proteins. Physiologically, pyroptosis acts as an initiator of innate immunity by inducing the release of cytokines, including IL-1β and IL-18, as well as other molecules, following cell membrane rupture. 6 See Figure 1. Figure 1 Mechanisms of initiation of pyroptosis. Pyroptosis is a non-apoptotic programmed cell death linked to in -Abstract Truncated-

The Role of Pyroptosis in Alzheimer's Disease

Research Progresses of Molecular Mechanism of Pyroptosis and Its Related Diseases

Research Progress of Pyroptosis in Alzheimer's Disease.

The Relationship Between Alzheimer's Disease and Pyroptosis and the Intervention Progress of Traditional Chinese Medicine

Molecular mechanism of pyroptosis and inflammasome activation

Research Progress of the Relationship Between Pyroptosis and Disease

Pyroptosis and degenerative diseases of the elderly

Amyloid-|[beta]| induces NLRP1-dependent neuronal pyroptosis in models of Alzheimer|[rsquo]|s disease

Amyloid-β induces NLRP1-dependent neuronal pyroptosis in models of Alzheimer's disease.

Amyloid-β Induces NLRP1-Dependent Neuronal Pyroptosis in Alzheimer's Disease (P1.239)

Role of pyroptosis in the pathogenesis of various neurological diseases

Pyroptosis Plays a Role in Osteoarthritis

Molecular Mechanism and Immunological Function of Pyroptosis

The role of pyroptosis in inflammatory diseases.

The Role of Mitochondria in Pyroptosis

Emerging Insights into Molecular Mechanisms Underlying Pyroptosis and Functions of Inflammasomes in Diseases

Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death

Role of Pyroptosis in Diabetes and Its Therapeutic Implications

Role of Pyroptosis in Respiratory Diseases and Its Therapeutic Potential

Role of pyroptosis in inflammation and cancer

Roles of pyroptosis in atherosclerosis pathogenesis